• Türkçe
    • English
  • Türkçe 
    • Türkçe
    • English
  • Giriş
Öğe Göster 
  •   DSpace@Muğla
  • Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed
  • WoS İndeksli Yayınlar Koleksiyonu
  • Öğe Göster
  •   DSpace@Muğla
  • Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed
  • WoS İndeksli Yayınlar Koleksiyonu
  • Öğe Göster
JavaScript is disabled for your browser. Some features of this site may not work without it.

First-Year Outcomes of Cataract Surgery Combined with Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration

Tarih

2019

Yazar

Sul, Sabahattin
Karalezli, Aylin
Karabulut, Mujdat

Üst veri

Tüm öğe kaydını göster

Özet

Objectives: To compare the first-year results of patients with active neovascular age-related macular degeneration (nAMD) under intravitreal ranibizumab (IVR) treatment who did and did not undergo cataract surgery. Materials and Methods: The records of 72 patients with active nAMD were reviewed retrospectively. Group 1 consisted of 23 patients who underwent uncomplicated cataract surgery and continued with IVR treatment and group 2 consisted of 49 patients without cataract who received only IVR treatment. The groups were compared according to pretreatment and first year best spectacle-corrected visual acuity (BCVA), central foveal thickness (CFT), number of injections, and nAMD activity (presence of subretinal or intraretinal fluid). Logarithm of minimum angle of resolution (LogMAR) was used for the determination of visual acuity. Activity findings were evaluated with optical coherence tomography. Results: Pretreatment BCVA was 0.94 +/- 0.21 in group 1 and 0.77 +/- 0.36 in group 2 (p=0.041). At the end of the first year, BCVA was 0.48 +/- 0.35 in group 1 and 0.49 +/- 0.33 in group 2 (p=0.902). BCVA change was 0.46 +/- 0.29 in group 1 and 0.28 +/- 0.31 in group 2 (p=0.026). Pretreatment CFT was 305 +/- 146 mu m in group 1 and 340 +/- 120 mu m in group 2 (p=0.292). At the end of the first year, CFT was 246 +/- 110 mu m and 245 +/- 82 mu m in group 2 (p=0.977). CFT change was 59 +/- 45 mu m in group 1 and 92 +/- 97 mu m in group 2 (p=0.135). Mean number of injections over 1 year was 6.2 +/- 1.9 in group 1 and 5.7 +/- 1.8 in group 2 (p=0.271). At the end of the first year, subretinal fluid was observed in 3 patients in group 1 (13%) and 5 patients in group 2 (10.2%) (p=0.721) and intraretinal fluid was present in 3 patients in group 1 (13%) and 4 patients in group 2 (8.2%) (p=0.515). Conclusion: Cataract surgery combined with IVR treatment yielded significant visual gain in patients with active nAMD. Anatomic results suggest that cataract surgery does not worsen nAMD.

Kaynak

Turk Oftalmoloji Dergisi-Turkish Journal of Ophthalmology

Cilt

49

Sayı

1

Bağlantı

https://doi.org/10.4274/tjo.galenos.2018.76429
https://app.trdizin.gov.tr//makale/TXpjME9USTVPUT09
https://hdl.handle.net/20.500.12809/1096

Koleksiyonlar

  • PubMed İndeksli Yayınlar Koleksiyonu [2082]
  • Scopus İndeksli Yayınlar Koleksiyonu [6219]
  • TR-Dizin İndeksli Yayınlar Koleksiyonu [3005]
  • WoS İndeksli Yayınlar Koleksiyonu [6466]



DSpace software copyright © 2002-2015  DuraSpace
İletişim | Geri Bildirim
Theme by 
@mire NV
 

 




| Politika | Rehber | İletişim |

DSpace@Muğla

by OpenAIRE
Gelişmiş Arama

sherpa/romeo

Göz at

Tüm DSpaceBölümler & KoleksiyonlarTarihe GöreYazara GöreBaşlığa GöreKonuya GöreTüre GöreDile GöreBölüme GöreKategoriye GöreYayıncıya GöreErişim ŞekliKurum Yazarına GöreBu KoleksiyonTarihe GöreYazara GöreBaşlığa GöreKonuya GöreTüre GöreDile GöreBölüme GöreKategoriye GöreYayıncıya GöreErişim ŞekliKurum Yazarına Göre

Hesabım

GirişKayıt

DSpace software copyright © 2002-2015  DuraSpace
İletişim | Geri Bildirim
Theme by 
@mire NV
 

 


|| Politika || Rehber|| Yönerge || Kütüphane || Muğla Sıtkı Koçman Üniversitesi || OAI-PMH ||

Muğla Sıtkı Koçman Üniversitesi, Muğla, Türkiye
İçerikte herhangi bir hata görürseniz, lütfen bildiriniz:

Creative Commons License
Muğla Sıtkı Koçman Üniversitesi Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..

DSpace@Muğla:


DSpace 6.2

tarafından İdeal DSpace hizmetleri çerçevesinde özelleştirilerek kurulmuştur.